Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 3.302.231.411.201.52

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 3.30 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20253.30
Mar20242.23
Mar20231.41
Mar20221.20
Mar20211.52

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 3.3
47.98
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2
-21.05
Mar2021 1.52 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,266.4 Cr -2.3% 1.3% 0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,786.0 Cr 0.5% 6.8% 16.3% Stock Analytics
DIVIS LABORATORIES ₹194,590.0 Cr 0.6% 8.7% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,658.0 Cr 0.4% 13.8% 46.9% Stock Analytics
CIPLA ₹115,728.0 Cr -0.4% 5.8% -2.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,708.0 Cr -1.9% -5.1% -2.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.3%

1.3%

0.9%

SENSEX

0.5%

0.1%

-6.1%


You may also like the below Video Courses